MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression <i>in vivo</i>Xin Zhang, Zhili Rong, Sihan Lv et al.|Nucleic Acids Research|2021Cited by 54
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificityHongxin Huang, Zhili Rong|BMC Biology|2022Cited by 52
An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer PatientsHongxin Huang, Xinggui Chen, Yayuan Zheng et al.|PLoS ONE|2014Cited by 33
Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinomaRenxian Xie, Chuangzhen Chen, Qingxin Cai et al.|Frontiers in Oncology|2024Cited by 14
Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysisRenxian Xie, Chuangzhen Chen, Hongxin Huang et al.|Frontiers in Pharmacology|2023Cited by 10